Toshiba America Medical Systems named Peter N.S. Annand tothe position of senior vice president of sales, marketing, serviceand ultrasound this month. The move provides company-wide seniormanagement support for TAMS president Kunio Sumikawa, which
Toshiba America Medical Systems named Peter N.S. Annand tothe position of senior vice president of sales, marketing, serviceand ultrasound this month. The move provides company-wide seniormanagement support for TAMS president Kunio Sumikawa, which hadbeen lacking for two years.
Annand will be the highest ranking non-Japanese in the multimodalityimaging vendor's U.S. operations, with responsibility for allmodality products. He fills the role at Tustin, CA-based TAMSthat was left vacant by the departure of Ronald B. Schilling in1991 (SCAN 1/29/92).
The executive comes to TAMS from Toshiba's Australiansubsidiary,where he was general manager of the medical division for fouryears. This division's sales grew 44% during his tenure. Annandhas 30 years' experience in the medical industry, having servedin Australia, Canada and the U.S.
In other Toshiba news, the vendor received Food and Drug Administration510(k) clearance last month for its Flexart 0.5-tesla MRI scanner.
Flexart is based on a high-speed RISC microprocessor and hasan icon-based X-Windows graphical user interface for easier operation.Flexart was introduced at last year's Radiological Society ofNorth America meeting (SCAN 11/17/93). The unit is Toshiba's premiummid-field offering.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.